140 filings
8-K
MIST
Milestone Pharmaceuticals Inc
13 May 24
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
7:34am
10-Q
2024 Q1
MIST
Milestone Pharmaceuticals Inc
Quarterly report
13 May 24
6:59am
8-K
MIST
Milestone Pharmaceuticals Inc
8 Apr 24
Data from this large safety-trial also published in The Journal of the American College of Cardiology
4:38pm
8-K
MIST
Milestone Pharmaceuticals Inc
28 Mar 24
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
7:07am
8-K
dcc huomn0
21 Mar 24
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update
7:21am
8-K
5jf8kvql
4 Mar 24
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
9:00am
424B5
4pxnl841h3lg wbwpnuv
1 Mar 24
Prospectus supplement for primary offering
4:52pm
424B5
kdu2vmu1p8bs
28 Feb 24
Prospectus supplement for primary offering
5:21pm
8-K
iseybexz8yn0eddvfb
26 Feb 24
Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
7:06am
8-K
5cdd7
26 Dec 23
Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT
7:15am
8-K
qv1j8gola87om3r0ax
13 Nov 23
Milestone Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Corporate Updates
7:05am
8-K
28fwmdk q4lz4
13 Nov 23
Company Overview CONFIDENTIAL Atrial Fibrillation Program Update November 2023
6:37am
8-K
5ove d6v29a5
7 Nov 23
Regulation FD Disclosure
9:07am
8-K
n9oqlx72jet8 1fo
24 Oct 23
Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil
4:05pm
8-K
w2b5j24t 43y3vf8
10 Aug 23
Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update
7:40am
8-K
6ekpv5ptyontp2iwu 3n
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:11pm